Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.
The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.
The 33-year-old’s symptoms may have been exacerbated by underlying conditions, including a recent bout of COVID-19.
A longer growing season means more sneezing and higher health care costs. Thanks, climate change!
Chronic wasting disease (CWD) is a prion disease that affects North American cervids (hoofed ruminant mammals, with males characteristically having antlers).
With two human cases of bird flu identified, health officials need to get ahead of a threat that some scientists fear could become next pandemic,…
Experimental evidence suggests that SARS-CoV-2 remains viable within aerosols with a half-life of approximately 3 hours; however, it remains unclear how long airborne SARS-CoV-2 can…
COVID-19 vaccines protect against COVID-19. Get safety info and more.
We are going to be as ready as any government or organization could possibly be, says NIH leader
We are going to be as ready as any government or organization could possibly be, says NIH leader
Theo Huot de Saint-Albin says long Covid “lurks” in the background, causing brain fog, pain and migraines that keep him from attending school regularly.
China reported a combined 32,380 cases of pertussis in January and February—compared with 1,421 cases during the same period in 2023. There were 13 deaths.